• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经鼻胰岛素改善22q13缺失综合征患儿发育迟缓:一项探索性临床试验。

Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial.

作者信息

Schmidt H, Kern W, Giese R, Hallschmid M, Enders A

机构信息

Dr von Hauner Children's Hospital, University of Munich, Lindwurmstr. 4, 80337 Munich, Germany.

出版信息

J Med Genet. 2009 Apr;46(4):217-22. doi: 10.1136/jmg.2008.062141. Epub 2008 Oct 23.

DOI:10.1136/jmg.2008.062141
PMID:18948358
Abstract

BACKGROUND

The 22q13 deletion syndrome (Phelan-McDermid syndrome) is characterised by a global developmental delay, absent or delayed speech, generalised hypotonia, autistic behaviour and characteristic phenotypic features. Intranasal insulin has been shown to improve declarative memory in healthy adult subjects and in patients with Alzheimer disease.

AIMS

To assess if intranasal insulin is also able to improve the developmental delay in children with 22q13 deletion syndrome.

METHODS

We performed exploratory clinical trials in six children with 22q13 deletion syndrome who received intranasal insulin over a period of 1 year. Short-term (during the first 6 weeks) and long-term effects (after 12 months of treatment) on motor skills, cognitive functions, or autonomous functions, speech and communication, emotional state, social behaviour, behavioural disorders, independence in daily living and education were assessed.

RESULTS

The children showed marked short-term improvements in gross and fine motor activities, cognitive functions and educational level. Positive long-term effects were found for fine and gross motor activities, nonverbal communication, cognitive functions and autonomy. Possible side effects were found in one patient who displayed changes in balance, extreme sensitivity to touch and general loss of interest. One patient complained of intermittent nose bleeding.

CONCLUSIONS

We conclude that long-term administration of intranasal insulin may benefit motor development, cognitive functions and spontaneous activity in children with 22q13 deletion syndrome.

摘要

背景

22q13缺失综合征(费伦 - 麦克德米德综合征)的特征为全面发育迟缓、言语缺失或延迟、全身肌张力减退、自闭症行为及特征性表型特征。鼻内胰岛素已被证明可改善健康成人及阿尔茨海默病患者的陈述性记忆。

目的

评估鼻内胰岛素是否也能改善22q13缺失综合征患儿的发育迟缓。

方法

我们对6名22q13缺失综合征患儿进行了探索性临床试验,这些患儿接受了为期1年的鼻内胰岛素治疗。评估了对运动技能、认知功能、自主功能、言语和沟通、情绪状态、社会行为、行为障碍、日常生活独立性和教育的短期(前6周)和长期影响(治疗12个月后)。

结果

患儿在粗大和精细运动活动、认知功能和教育水平方面表现出明显的短期改善。在精细和粗大运动活动、非言语沟通、认知功能和自主性方面发现了积极的长期影响。在一名患者中发现了可能的副作用,该患者表现出平衡改变、对触摸极度敏感和普遍兴趣丧失。一名患者抱怨间歇性鼻出血。

结论

我们得出结论,长期给予鼻内胰岛素可能有益于22q13缺失综合征患儿的运动发育、认知功能和自发活动。

相似文献

1
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial.经鼻胰岛素改善22q13缺失综合征患儿发育迟缓:一项探索性临床试验。
J Med Genet. 2009 Apr;46(4):217-22. doi: 10.1136/jmg.2008.062141. Epub 2008 Oct 23.
2
Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).缺失大小与重要表型之间的关联扩大了 Phelan-McDermid 综合征(22q13 缺失综合征)的感兴趣基因组区域。
J Med Genet. 2011 Nov;48(11):761-6. doi: 10.1136/jmedgenet-2011-100225. Epub 2011 Oct 7.
3
Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial.鼻内胰岛素对费兰-麦克德米德综合征的发育和行为有影响吗?一项随机、双盲、安慰剂对照试验。
Eur J Hum Genet. 2016 Dec;24(12):1696-1701. doi: 10.1038/ejhg.2016.109. Epub 2016 Aug 31.
4
22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay.22q13.3缺失综合征:一种与明显言语和语言发育迟缓相关的可识别的畸形综合征。
Am J Med Genet C Semin Med Genet. 2007 Nov 15;145C(4):393-8. doi: 10.1002/ajmg.c.30155.
5
Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.使用基于染色体特异性阵列的比较基因组杂交技术对具有亚端粒22q异常的患者进行分子特征分析。
Eur J Hum Genet. 2005 Sep;13(9):1019-24. doi: 10.1038/sj.ejhg.5201456.
6
Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood.儿童22q13.3缺失综合征的神经行为特征与脑成像研究
Pediatrics. 2008 Aug;122(2):e376-82. doi: 10.1542/peds.2007-2584. Epub 2008 Jul 14.
7
[The Phelan-McDermid syndrome (22q13 microdeletion) - case report].[费伦-麦克德米德综合征(22q13微缺失)——病例报告]
Med Wieku Rozwoj. 2011 Jan-Mar;15(1):96-100.
8
Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3.22q13.3染色体缺失综合征,伴有新发的22q13.3间质隐匿性缺失,破坏了SHANK3基因。
Eur J Med Genet. 2009 Sep-Oct;52(5):328-32. doi: 10.1016/j.ejmg.2009.05.004. Epub 2009 May 18.
9
Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion.22q11.2染色体缺失的学龄前儿童的认知和行为特征
Am J Med Genet. 1999 Jul 16;85(2):127-33.
10
The deletion 22q13 syndrome: a new case.22q13缺失综合征:一例新病例。
Genet Couns. 2015;26(1):53-60.

引用本文的文献

1
Diagnosis and treatment of bipolar disorder in Phelan-McDermid syndrome: A case report and review of literature.费兰-麦克德米德综合征中双相情感障碍的诊断与治疗:一例病例报告及文献综述
World J Psychiatry. 2025 Feb 19;15(2):101948. doi: 10.5498/wjp.v15.i2.101948.
2
An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndrome.一项评估AMO-01治疗费兰-麦克德米德综合征癫痫安全性和有效性的开放标签研究。
HGG Adv. 2025 Apr 10;6(2):100393. doi: 10.1016/j.xhgg.2024.100393. Epub 2024 Dec 16.
3
Intranasal Immunotherapy with M2 Macrophage Secretome Ameliorates Language Impairments and Autistic-like Behavior in Children.
用M2巨噬细胞分泌组进行鼻内免疫疗法可改善儿童的语言障碍和自闭症样行为。
J Clin Med. 2024 May 24;13(11):3079. doi: 10.3390/jcm13113079.
4
Opportunities for ABA intervention in Phelan-McDermid syndrome.应用行为分析(ABA)对费兰-麦克德米德综合征进行干预的机会。
Int J Dev Disabil. 2021 Mar 9;68(6):984-989. doi: 10.1080/20473869.2021.1895698. eCollection 2022.
5
Clinical and Genetic Aspects of Phelan-McDermid Syndrome: An Interdisciplinary Approach to Management.《Phelan-McDermid 综合征的临床和遗传方面:管理的跨学科方法》
Genes (Basel). 2022 Mar 12;13(3):504. doi: 10.3390/genes13030504.
6
Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications.SHANK3 缺失症在动物模型中的比较:表型、治疗策略及转化意义。
J Neurodev Disord. 2021 Nov 16;13(1):55. doi: 10.1186/s11689-021-09397-8.
7
Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome.遗传发现作为普氏综合征个体化药物治疗的潜在基础。
Genes (Basel). 2021 Jul 30;12(8):1192. doi: 10.3390/genes12081192.
8
Intranasal insulin rescues repeated anesthesia-induced deficits in synaptic plasticity and memory and prevents apoptosis in neonatal mice via mTORC1.鼻腔内给予胰岛素可通过 mTORC1 挽救新生小鼠反复麻醉诱导的突触可塑性和记忆缺陷,并防止细胞凋亡。
Sci Rep. 2021 Jul 29;11(1):15490. doi: 10.1038/s41598-021-94849-3.
9
Examining factors affecting parental satisfaction with speech therapy in children with Phelan-McDermid Syndrome.探究影响患有费兰-麦克德米德综合征儿童的父母对言语治疗满意度的因素。
Int J Dev Disabil. 2019 Mar 27;66(4):304-316. doi: 10.1080/20473869.2019.1582906.
10
Cross-sectional investigation of insulin resistance in youths with autism spectrum disorder. Any role for reduced brain glucose metabolism?自闭症谱系障碍青少年胰岛素抵抗的横断面研究。脑葡萄糖代谢减少是否起作用?
Transl Psychiatry. 2021 Apr 20;11(1):229. doi: 10.1038/s41398-021-01345-3.